Does Atogepant Interact with Topiramate?
Atogepant and Topiramate have a moderate drug interaction according to U.S. FDA drug labeling data. Weak CYP3A4 inducer resulting in decreased atogepant exposure; dosage adjustment may be needed with monitoring for reduced efficacy. The mechanism involves cyp3a4 induction. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This information is based on official FDA drug labeling sourced from OpenFDA and the NIH National Library of Medicine.
- Severity
- Moderate
- Atogepant Class
- Calcitonin Gene-related Peptide Receptor Antagonist
- Topiramate Class
- Cytochrome P450 3A4 Inducers
- Management
- Monitor for effects
- Data Source
- U.S. FDA via OpenFDA
How This Interaction Works
The interaction between Atogepant and Topiramate occurs because cyp3a4 induction. Clinically, this means weak cyp3a4 inducer resulting in decreased atogepant exposure; dosage adjustment may be needed with monitoring for reduced efficacy. This is classified as a moderate interaction. While it may not require stopping either medication, your healthcare provider should be aware you are taking both so they can monitor for potential effects and adjust treatment if necessary.
What To Tell Your Doctor or Pharmacist
If you are taking Atogepant and your doctor is considering prescribing Topiramate (or vice versa), make sure to:
- Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
- Ask whether the benefits of combining these medications outweigh the risks for your specific situation
- Ask what symptoms to watch for that would indicate the interaction is causing problems
- Ask whether any dosage adjustments are needed
- Never stop or change either medication without first consulting your healthcare provider